✦ LIBER ✦

Phase II study of the combination carboplatinpluscelecoxib in heavily pre-treated recurrent ovarian cancer patients

✍ Scribed by Francesco Legge; Amelia Paglia; Marco D’Asta; Gilda Fuoco; Giovanni Scambia; Gabriella Ferrandina

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of weekly topotecan and

✍ Divya Gupta; Ricky L. Owers; Mimi Kim; Dennis Yi-Shin Kuo; Gloria S. Huang; Shoh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A phase II trial of capecitabine in heav

✍ Danny Rischin; Kelly-Anne Phillips; Michael Friedlander; Paul Harnett; Michael Q 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase II study of single-agent gemcitabi

✍ Yoh Watanabe; Eiji Koike; Hidekatsu Nakai; Tomomaro Etoh; Hiroshi Hoshiai 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 237 KB

Phase II study of pirarubicin combined w

✍ A. du Bois; H. G. Meerpohl; H. Madjar; D. Spinner; P. Dall; J. Pfisterer; T. Bau 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 693 KB

A phase II study of irofulven in women w

✍ Michael V. Seiden; Alan N. Gordon; Diane C. Bodurka; Ursula A. Matulonis; Richar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Phase II study of carboplatin in recurre

✍ Nicoletta Colombo; James L. Speyer; Michael Green; Renzo Canetta; Uziel Beller; 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 617 KB